Is indicated for the treatment of hypertension and heart failure
Lupin’s US subsidiary, Lupin Pharmaceuticals has launched its Valsartan tablets USP, 40 mg, 80 mg, 160 mg and 320 mg, the generic for Novartis Pharmaceuticals Corporation’s (Novartis) Diovan tablets 40 mg, 80 mg, 160 mg and 320 mg strengths and has received final approval from the United States Food and Drug Administration (US FDA).
Lupin’s Valsartan tablets 40 mg, 80 mg, 160 mg and 320 mg are the AB rated generic equivalent of Novartis’s Diovan tablets and is indicated for the treatment of hypertension and heart failure.
Diovan tablets had annual US sales of $ 2.08 billion.
EP News Bureau – Mumbai